Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis
Table 1
HS patients included in the study and assessed with ECG.
Age (years)
Sex
Height (cm)
Weight (kg)
BMI
Smoke
HR (bpm)
RR (ms)
PQ (ms)
QRS (ms)
QTc (ms)
41
F
1.68
83
29.4
Yes
78
768
114
88
324.00
16
F
1.65
72
26.4
No
93
642
148
58
296.00
31
M
1.7
95
32.9
Yes
81
740
140
92
344.00
15
M
1.62
93
35.4
No
87
690
140
78
332.00
48
M
1.8
90
27.8
Yes
60
1004
170
84
410.00
13
F
1.42
79
39.2
No
89
672
134
80
303.00
28
F
1.7
85
29.4
Yes
74
816
98
70
361.00
16
M
1.85
85
24.8
No
59
1020
152
88
404.00
36
M
1.66
77
27.9
No
70
856
148
88
370.00
19
F
1.76
72
23.2
No
78
768
122
76
324.00
32
F
1.65
83
30.5
Yes
79
758
148
86
322.00
28
F
1.57
76
30.8
Yes
67
892
144
84
349.00
24
F
1.7
130
45
Yes
93
644
156
88
297.00
16
F
1.67
60
21.5
No
83
720
172
108
314.00
22
M
1.85
95
27.8
Yes
74
806
104
110
359.00
21
M
70
1.85
20.5
No
69
866
120
88
372.00
25.38
6.23
79.80
29.53
77.125
791.375
138.125
85.375
342
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
